Evogene Ltd. (EVGN) is priced at $6.42 after the most recent trading session. At the very opening of the session, the stock price was $5.51 and reached a high price of $6.49, prior to closing the session it reached the value of $5.95. The stock touched a low price of $5.47.
Recently in News on January 5, 2021, Evogene Provides 2020 Year-End Update for CRISPR-IL Consortium. Progress includes completion of a first version of the artificial intelligence-driven platform for genome-editing. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Evogene Ltd. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $6.94 on 01/15/21, with the lowest value was $4.44 for the same time period, recorded on 01/06/21.
Evogene Ltd. (EVGN) full year performance was 250.56%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Evogene Ltd. shares are logging -1.08% during the 52-week period from high price, and 756.00% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.75 and $6.49.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1194703 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Evogene Ltd. (EVGN) recorded performance in the market was 26.60%, having the revenues showcasing 56.58% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 211.67M, as it employees total of 143 workers.
Market experts do have their say about Evogene Ltd. (EVGN)
During the last month, 0 analysts gave the Evogene Ltd. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.49, with a change in the price was noted +4.97. In a similar fashion, Evogene Ltd. posted a movement of +355.00% for the period of last 100 days, recording 1,402,852 in trading volumes.
Technical breakdown of Evogene Ltd. (EVGN)
Raw Stochastic average of Evogene Ltd. in the period of last 50 days is set at 87.50%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 82.83%. In the last 20 days, the company’s Stochastic %K was 81.80% and its Stochastic %D was recorded 75.19%.
Bearing in mind the latest performance of Evogene Ltd., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 26.60%. Additionally, trading for the stock in the period of the last six months notably improved by 461.32%, alongside a boost of 250.56% for the period of the last 12 months. The shares increased approximately by 15.53% in the 7-day charts and went down by 50.25% in the period of the last 30 days. Common stock shares were driven by 56.58% during last recorded quarter.